Morphic Therapeutic, Inc.
14Patents
14Active
14Granted
49Portfolio score
Filing activity: Feb 27, 2018 → Dec 22, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11040955B2 | Inhibitors of (alpha-v)(beta-6) integrin | Chemistry; Metallurgy | 5 | Active |
| US11021480B2 | Inhibiting (α-V)(β-6) integrin | Human Necessities | 5 | Active |
| US11046685B2 | Inhibitors of (α-v)(β-6) integrin | Human Necessities | 5 | Active |
| US11046669B2 | Inhibitors of (α-v)(β-6) integrin | Chemistry; Metallurgy | 5 | Active |
| US10759756B2 | Antagonists of human integrin α4β7 | Chemistry; Metallurgy | 4 | Active |
| US11739087B2 | Inhibiting (α-v)(β-6) integrin | Human Necessities | 2 | Active |
| US11370773B1 | Inhibiting human integrin (alpha-4) (beta-7) | Chemistry; Metallurgy | 2 | Active |
| US11795167B2 | Inhibitors of (α-v)(β-6) integrin | Human Necessities | 2 | Active |
| US11827621B2 | Inhibitors of (α-v)(β-6) integrin | Chemistry; Metallurgy | 2 | Active |
| US11104661B1 | Inhibiting human integrin (α-4) (β-7) | Chemistry; Metallurgy | 1 | Active |
| US12145935B2 | Inhibitors of (α-v)(β-6) integrin | Human Necessities | 1 | Active |
| US11174228B2 | Antagonists of human integrin (α4)(β7) | Chemistry; Metallurgy | 1 | Active |
| US12415796B2 | Inhibitors of (αv)(β6) integrin | Chemistry; Metallurgy | 0 | Active |
| US12221416B2 | Antagonists of human integrin α4β7 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.